180 related articles for article (PubMed ID: 23395589)
1. Androgenetic alopecia and risk of prostate cancer: a systematic review and meta-analysis.
Amoretti A; Laydner H; Bergfeld W
J Am Acad Dermatol; 2013 Jun; 68(6):937-43. PubMed ID: 23395589
[TBL] [Abstract][Full Text] [Related]
2. Possible association between androgenic alopecia and risk of prostate cancer and testicular germ cell tumor: a systematic review and meta-analysis.
Liang W; Song L; Peng Z; Zou Y; Dai S
BMC Cancer; 2018 Mar; 18(1):279. PubMed ID: 29529997
[TBL] [Abstract][Full Text] [Related]
3. Association between male pattern baldness and prostate disease: A meta-analysis.
Jin T; Wu T; Luo Z; Duan X; Deng S; Tang Y
Urol Oncol; 2018 Feb; 36(2):80.e7-80.e15. PubMed ID: 29054497
[TBL] [Abstract][Full Text] [Related]
4. Male pattern baldness and the risk of prostate cancer.
Yassa M; Saliou M; De Rycke Y; Hemery C; Henni M; Bachaud JM; Thiounn N; Cosset JM; Giraud P
Ann Oncol; 2011 Aug; 22(8):1824-7. PubMed ID: 21324955
[TBL] [Abstract][Full Text] [Related]
5. Patients with a large prostate show a higher prevalence of androgenetic alopecia.
Chen W; Yang CC; Chen GY; Wu MC; Sheu HM; Tzai TS
Arch Dermatol Res; 2004 Nov; 296(6):245-9. PubMed ID: 15517324
[TBL] [Abstract][Full Text] [Related]
6. Higher body mass index is associated with greater severity of alopecia in men with male-pattern androgenetic alopecia in Taiwan: a cross-sectional study.
Yang CC; Hsieh FN; Lin LY; Hsu CK; Sheu HM; Chen W
J Am Acad Dermatol; 2014 Feb; 70(2):297-302.e1. PubMed ID: 24184140
[TBL] [Abstract][Full Text] [Related]
7. Male-Pattern Vertex Baldness Trajectories, Chest Hair Patterns, and Odds of Overall and Aggressive Prostate Cancer.
Salmon C; Mesidor M; Rousseau MC; Richard H; Weiss D; Spence AR; Parent ME
Cancer Epidemiol Biomarkers Prev; 2024 Jan; 33(1):143-150. PubMed ID: 37851110
[TBL] [Abstract][Full Text] [Related]
8. Early onset baldness and prostate cancer risk.
Denmark-Wahnefried W; Schildkraut JM; Thompson D; Lesko SM; McIntyre L; Schwingl P; Paulson DF; Robertson CN; Anderson EE; Walther PJ
Cancer Epidemiol Biomarkers Prev; 2000 Mar; 9(3):325-8. PubMed ID: 10750672
[TBL] [Abstract][Full Text] [Related]
9. Androgenetic alopecia in men aged 40-69 years: prevalence and risk factors.
Severi G; Sinclair R; Hopper JL; English DR; McCredie MR; Boyle P; Giles GG
Br J Dermatol; 2003 Dec; 149(6):1207-13. PubMed ID: 14674898
[TBL] [Abstract][Full Text] [Related]
10. Age-dependent associations between androgenetic alopecia and prostate cancer risk.
Muller DC; Giles GG; Sinclair R; Hopper JL; English DR; Severi G
Cancer Epidemiol Biomarkers Prev; 2013 Feb; 22(2):209-15. PubMed ID: 23074289
[TBL] [Abstract][Full Text] [Related]
11. Androgenetic alopecia and cardiovascular risk factors in men and women: a comparative study.
Arias-Santiago S; Gutiérrez-Salmerón MT; Castellote-Caballero L; Buendía-Eisman A; Naranjo-Sintes R
J Am Acad Dermatol; 2010 Sep; 63(3):420-9. PubMed ID: 20619491
[TBL] [Abstract][Full Text] [Related]
12. Androgenetic alopecia and polymorphism of the androgen receptor gene (SNP rs6152) in patients with benign prostate hyperplasia or prostate cancer.
Kucerova R; Bienova M; Kral M; Bouchal J; Trtkova KS; Burdova A; Student V; Kolar Z
J Eur Acad Dermatol Venereol; 2015 Jan; 29(1):91-6. PubMed ID: 24665929
[TBL] [Abstract][Full Text] [Related]
13. Early onset of androgenetic alopecia associated with early severe coronary heart disease: a population-based, case-control study.
Matilainen VA; Mäkinen PK; Keinänen-Kiukaanniemi SM
J Cardiovasc Risk; 2001 Jun; 8(3):147-51. PubMed ID: 11455846
[TBL] [Abstract][Full Text] [Related]
14. Androgenetic alopecia as an early marker of benign prostatic hyperplasia.
Arias-Santiago S; Arrabal-Polo MA; Buendía-Eisman A; Arrabal-Martín M; Gutiérrez-Salmerón MT; Girón-Prieto MS; Jimenez-Pacheco A; Calonje JE; Naranjo-Sintes R; Zuluaga-Gomez A; Serrano Ortega S
J Am Acad Dermatol; 2012 Mar; 66(3):401-8. PubMed ID: 21835498
[TBL] [Abstract][Full Text] [Related]
15. Androgenetic alopecia and prostate cancer: findings from an Australian case-control study.
Giles GG; Severi G; Sinclair R; English DR; McCredie MR; Johnson W; Boyle P; Hopper JL
Cancer Epidemiol Biomarkers Prev; 2002 Jun; 11(6):549-53. PubMed ID: 12050096
[TBL] [Abstract][Full Text] [Related]
16. Serum androgens and prostate-specific antigen levels in androgenetic alopecia: is there a difference between frontal and vertex baldness?
Lis-Święty A; Arasiewicz H; Ranosz-Janicka I; Brzezińska-Wcisło L
J Eur Acad Dermatol Venereol; 2018 Oct; 32(10):1815-1818. PubMed ID: 29237093
[TBL] [Abstract][Full Text] [Related]
17. Androgenetic alopecia as an indicator of metabolic syndrome and cardiovascular risk.
Ertas R; Orscelik O; Kartal D; Dogan A; Ertas SK; Aydogdu EG; Ascioglu O; Borlu M
Blood Press; 2016 Jun; 25(3):141-8. PubMed ID: 26585114
[TBL] [Abstract][Full Text] [Related]
18. Male pattern baldness and incidence of prostate cancer: A systematic review and meta-analysis.
He H; Xie B; Xie L
Medicine (Baltimore); 2018 Jul; 97(28):e11379. PubMed ID: 29995779
[TBL] [Abstract][Full Text] [Related]
19. Male pattern baldness in relation to prostate cancer risks: an analysis in the VITamins and lifestyle (VITAL) cohort study.
Zhou CK; Littman AJ; Levine PH; Hoffman HJ; Cleary SD; White E; Cook MB
Prostate; 2015 Mar; 75(4):415-23. PubMed ID: 25492530
[TBL] [Abstract][Full Text] [Related]
20. Relationship between male pattern baldness and the risk of aggressive prostate cancer: an analysis of the Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial.
Zhou CK; Pfeiffer RM; Cleary SD; Hoffman HJ; Levine PH; Chu LW; Hsing AW; Cook MB
J Clin Oncol; 2015 Feb; 33(5):419-25. PubMed ID: 25225425
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
